PCR181 Health-Related Quality-of-Life of Patients Treated with Repotrectinib for Neurotrophic Tyrosine Receptor Kinase (NTRK)-Positive Advanced Solid Tumors: Results from TRIDENT-1.
Saved in:
| Title: | PCR181 Health-Related Quality-of-Life of Patients Treated with Repotrectinib for Neurotrophic Tyrosine Receptor Kinase (NTRK)-Positive Advanced Solid Tumors: Results from TRIDENT-1. |
|---|---|
| Authors: | Sherif, B.1 (AUTHOR), Besse, B.2 (AUTHOR), Solomon, B.3 (AUTHOR), Bazhenova, L.4 (AUTHOR), Kim, D.W.5 (AUTHOR), Lin, J.J.6 (AUTHOR), Wolf, J.7 (AUTHOR), Popat, S.8 (AUTHOR), Goto, K.9 (AUTHOR), de Langen, A.J.10 (AUTHOR), Springfeld, C.11 (AUTHOR), Reynolds, M.1 (AUTHOR), Odom, D.1 (AUTHOR), Yuan, Y.12 (AUTHOR), Lee, A.13 (AUTHOR), Blum, S.I.12 (AUTHOR), Thamake, S.12 (AUTHOR), Ades, F.12 (AUTHOR), Drilon, A.14 (AUTHOR) |
| Source: | Value in Health. 2023 Supplement, Vol. 26 Issue 12, pS484-S484. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 10983015 |
|---|---|
| DOI: | 10.1016/j.jval.2023.09.2619 |
